Indicators

Markets:

News

Novo Nordisk A/S Common Stock (NY:NVO)

46.98 -0.10 (-0.21%)

Streaming Delayed Price Updated: 9:34 AM EDT, Aug 3, 2026 Add to My Watchlist

Price and Volume

Volume	768,629
Open	47.05
Bid (Size)	46.97 (400)
Ask (Size)	46.99 (400)
Prev. Close	47.08
Today's Range	46.88 - 47.14
52wk Range	35.12 - 64.16
Shares Outstanding	N/A
Dividend Yield	5.43%

Chart for (: )

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

News headline image

Bearish Pressure Is Building Around These 3 Stocks ↗

Today 8:35 EDT

Hims & Hers Health and QXO face heavy short interest amid dilution and loss concerns, while KLA has slid nearly 40% since June as AI-driven chip spending fears grip semiconductor stocks.

News headline image

Novo Nordisk Shares Plunge After a Key Trial Fails. Should Investors Buy the Dip? ↗

July 31, 2026

With the stock near a 5-year low, is it worth a look?

Via The Motley Fool

Performance

YTD	-10.3%	-10.3%
1 Month	-4.6%	-4.6%
3 Month	+5.8%	+5.8%
6 Month	-20.3%	-20.3%
1 Year	-3.7%	-3.7%

More News

News headline image

Eli Lilly Stock Has Skyrocketed. Novo Nordisk Has Crashed. 1 Number Explains Why They're Not Even Close Anymore. ↗

July 31, 2026

Via The Motley Fool

News headline image

3 Beaten-Down Stocks With GLP-1 Exposure to Buy and Hold ↗

July 29, 2026

Via The Motley Fool

News headline image

Watch Out, Eli Lilly and Novo Nordisk: Amgen's Monthly Weight Loss Drug Has 6 Phase 3 Trials Running -- and It's Coming for Your Patients ↗

July 29, 2026

Via The Motley Fool

News headline image

Where Will Novo Nordisk Stock Be in 3 Years? ↗

July 28, 2026

Via The Motley Fool

News headline image

Why Is Novo Nordisk Suing Eli Lilly, and What Does it Mean for Investors? ↗

July 24, 2026

Via The Motley Fool

News headline image

2 Top Growth Stocks to Buy Right Now Without Any Hesitation ↗

July 24, 2026

Via The Motley Fool

News headline image

3 Absurdly Cheap Dividend Stocks to Buy With $1,000 Right Now ↗

July 23, 2026

Via The Motley Fool

News headline image

"Deceptive Advertising!" Claims Novo Nordisk in Explosive New GLP-1 Lawsuit Against Eli Lilly. Here's What That Means for Both Stocks. ↗

July 21, 2026

Via The Motley Fool

News headline image

Novo Nordisk's Dividend Story Is Changing -- Here's What Investors Are Missing ↗

July 21, 2026

Via The Motley Fool

News headline image

Next-Generation Diabetes Therapies Are Reshaping Healthcare and Creating MultiBillion-Dollar Revenue Opportunities

July 21, 2026

Via FinancialNewsMedia

News headline image

Could Pfizer Ultimately Be the Biggest Winner in the $100 Billion Weight-Loss Market? ↗

July 20, 2026

Via The Motley Fool

News headline image

Watch Out, Eli Lilly and Novo Nordisk: Viking Therapeutics Just Started Testing a Weight Loss Drug That Goes Beyond GLP-1 ↗

July 18, 2026

Via The Motley Fool

News headline image

The Most Overlooked Reason Eli Lilly Stock Keeps Surging -- and It Has Nothing to Do With Weight Loss ↗

July 17, 2026

Via The Motley Fool

News headline image

Wegovy Pill Just Changed the GLP-1 Market. Here's Why Eli Lilly Stock Could Still Win ↗

July 17, 2026

Via The Motley Fool

News headline image

3 High-Yield Dividend Stocks to Buy and Hold ↗

July 17, 2026

Via The Motley Fool

News headline image

This GLP-1 Stock Could Double by 2030. Here's Why ↗

July 16, 2026

Via The Motley Fool

News headline image

2 Beaten-Down GLP-1 Stocks to Buy on the Dip ↗

July 15, 2026

Via The Motley Fool

News headline image

Is This Disturbing Trend Bad News for Eli Lilly in the Billion-Dollar Obesity Drug Market? ↗

July 14, 2026

Via The Motley Fool

News headline image

3 Dividend Stocks That Are No-Brainer Buys Heading Into the Second Half of 2026 ↗

July 11, 2026

Via The Motley Fool

News headline image

Should You Buy Eli Lilly Stock? Here's My Honest Take. ↗

July 11, 2026

Via The Motley Fool

News headline image

Is Pfizer on Track to Launch Its Next Lipitor -- This Time in the Weight-Loss Market? ↗

July 10, 2026

Via The Motley Fool

News headline image

Here's Why Shares in Novo Nordisk Rival, Agios Pharmaceutical, Soared This Week ↗

July 10, 2026

Via The Motley Fool

News headline image

Is It Too Late to Buy Eli Lilly? ↗

July 08, 2026

Via The Motley Fool

Frequently Asked Questions

Is Novo Nordisk A/S Common Stock publicly traded?

Yes, Novo Nordisk A/S Common Stock is publicly traded.

What exchange does Novo Nordisk A/S Common Stock trade on?

Novo Nordisk A/S Common Stock trades on the New York Stock Exchange

What is the ticker symbol for Novo Nordisk A/S Common Stock?

The ticker symbol for Novo Nordisk A/S Common Stock is NVO on the New York Stock Exchange

What is the current price of Novo Nordisk A/S Common Stock?

The current price of Novo Nordisk A/S Common Stock is 46.98

When was Novo Nordisk A/S Common Stock last traded?

The last trade of Novo Nordisk A/S Common Stock was at 08/03/26 09:34 AM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.